Ivermectin is under Evaluation for Covid-19 Treatment under NIH Guidelines

The controversy about Ivermectin takes another twisted turn as we now find out that the much feared and maligned Ivermectin is actually under evaluation for approval as a treatment protocol by the NIH.

Dr. Ardis breaks it down and his research is based on documents on the NIH website linked below.

NIH OVID-19 Treatment Guidelines Ivermectin Adults:

• The dose most commonly used in clinical trials is IVM 0.2–0.6 mg/kg PO given as a single dose or as a once-daily dose for up to 5 days.

Links;

• Table 2e. Characteristics of Antiviral Agents That Are Approved or Under Evaluation for the Treatment of COVID-19

• Ivermectin (Stromectol) [package insert]. Food and Drug Administration. 2009.